Foreign Generic Drug Use Is Key To Rx Price Equity, FDA’s McClellan Says
Executive Summary
Foreign countries could redirect billions of dollars into medical innovation by encouraging generic drug use, FDA Commissioner McClellan suggested in a speech to the Drug Information Association in Ottawa, Canada Nov. 18
You may also be interested in...
Global Price Controls Elimination May Not Affect U.S. Rx Costs – Economist
Eliminating pharmaceutical price controls in foreign countries would result in more innovation, but not necessarily lower prices for U.S. consumers, American Enterprise Institute economist Kevin Hassett said during an International Trade Administration meeting Aug. 3
Global Price Controls Elimination May Not Affect U.S. Rx Costs – Economist
Eliminating pharmaceutical price controls in foreign countries would result in more innovation, but not necessarily lower prices for U.S. consumers, American Enterprise Institute economist Kevin Hassett said during an International Trade Administration meeting Aug. 3
Rx Pricing Study Could Help Convince Trade Partners To Lift Price Controls
An international drug pricing study mandated by the Medicare Rx law may help convince developed countries to remove price controls, Commerce Department Under Secretary for International Trade Grant Aldonas said